-
1
-
-
0030749321
-
Skeletal complications of malignancy
-
R.E. Coleman Skeletal complications of malignancy Cancer 80 1997 1588 1594
-
(1997)
Cancer
, vol.80
, pp. 1588-1594
-
-
Coleman, R.E.1
-
2
-
-
79551505431
-
The use of bisphosphonates in cancer treatment
-
R. Coleman The use of bisphosphonates in cancer treatment Ann. N. Y. Acad. Sci. 1218 2011 3 14
-
(2011)
Ann. N. Y. Acad. Sci.
, vol.1218
, pp. 3-14
-
-
Coleman, R.1
-
3
-
-
0037673933
-
Control of osteoblast function and regulation of bone mass
-
S. Harada, and G.A. Rodan Control of osteoblast function and regulation of bone mass Nature 423 2003 349 355
-
(2003)
Nature
, vol.423
, pp. 349-355
-
-
Harada, S.1
Rodan, G.A.2
-
5
-
-
10144241022
-
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
-
T.A. Guise, J.J. Yin, S.D. Taylor, Y. Kumagai, M. Dallas, B.F. Boyce, T. Yoneda, and G.R. Mundy Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis J. Clin. Invest. 98 1996 1544 1549
-
(1996)
J. Clin. Invest.
, vol.98
, pp. 1544-1549
-
-
Guise, T.A.1
Yin, J.J.2
Taylor, S.D.3
Kumagai, Y.4
Dallas, M.5
Boyce, B.F.6
Yoneda, T.7
Mundy, G.R.8
-
7
-
-
0037303203
-
Role of endothelin-1 in osteoblastic bone metastases
-
T.A. Guise, J.J. Yin, and K.S. Mohammad Role of endothelin-1 in osteoblastic bone metastases Cancer 97 2003 779 784
-
(2003)
Cancer
, vol.97
, pp. 779-784
-
-
Guise, T.A.1
Yin, J.J.2
Mohammad, K.S.3
-
8
-
-
80054035939
-
A. Investigators breast-cancer adjuvant therapy with zoledronic acid
-
R.E. Coleman, H. Marshall, D. Cameron, D. Dodwell, R. Burkinshaw, M. Keane, M. Gil, S.J. Houston, R.J. Grieve, P.J. Barrett-Lee, D. Ritchie, J. Pugh, C. Gaunt, U. Rea, J. Peterson, C. Davies, V. Hiley, W. Gregory, R. Bell, and A. Investigators Breast-cancer adjuvant therapy with zoledronic acid N. Engl. J. Med. 365 2011 1396 1405
-
(2011)
N. Engl. J. Med.
, vol.365
, pp. 1396-1405
-
-
Coleman, R.E.1
Marshall, H.2
Cameron, D.3
Dodwell, D.4
Burkinshaw, R.5
Keane, M.6
Gil, M.7
Houston, S.J.8
Grieve, R.J.9
Barrett-Lee, P.J.10
Ritchie, D.11
Pugh, J.12
Gaunt, C.13
Rea, U.14
Peterson, J.15
Davies, C.16
Hiley, V.17
Gregory, W.18
Bell, R.19
-
9
-
-
84855516339
-
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: Results of a phase 3, randomised, placebo-controlled trial
-
M.R. Smith, F. Saad, R. Coleman, N. Shore, K. Fizazi, B. Tombal, K. Miller, P. Sieber, L. Karsh, R. Damiao, T.L. Tammela, B. Egerdie, H. Van Poppel, J. Chin, J. Morote, F. Gomez-Veiga, T. Borkowski, Z. Ye, A. Kupic, R. Dansey, and C. Goessl Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial Lancet 379 2012 39 46
-
(2012)
Lancet
, vol.379
, pp. 39-46
-
-
Smith, M.R.1
Saad, F.2
Coleman, R.3
Shore, N.4
Fizazi, K.5
Tombal, B.6
Miller, K.7
Sieber, P.8
Karsh, L.9
Damiao, R.10
Tammela, T.L.11
Egerdie, B.12
Van Poppel, H.13
Chin, J.14
Morote, J.15
Gomez-Veiga, F.16
Borkowski, T.17
Ye, Z.18
Kupic, A.19
Dansey, R.20
Goessl, C.21
more..
-
10
-
-
0034060152
-
Development of our current understanding of bioactive lysophospholipids
-
W.H. Moolenaar Development of our current understanding of bioactive lysophospholipids Ann. N. Y. Acad. Sci. 905 2000 1 10
-
(2000)
Ann. N. Y. Acad. Sci.
, vol.905
, pp. 1-10
-
-
Moolenaar, W.H.1
-
11
-
-
77954338009
-
Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts
-
M. David, E. Wannecq, F. Descotes, S. Jansen, B. Deux, J. Ribeiro, C.M. Serre, S. Gres, N. Bendriss-Vermare, M. Bollen, S. Saez, J. Aoki, J.S. Saulnier-Blache, P. Clezardin, and O. Peyruchaud Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts PLoS One 5 2010 e9741
-
(2010)
PLoS One
, vol.5
, pp. 9741
-
-
David, M.1
Wannecq, E.2
Descotes, F.3
Jansen, S.4
Deux, B.5
Ribeiro, J.6
Serre, C.M.7
Gres, S.8
Bendriss-Vermare, N.9
Bollen, M.10
Saez, S.11
Aoki, J.12
Saulnier-Blache, J.S.13
Clezardin, P.14
Peyruchaud, O.15
-
12
-
-
33744830292
-
Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells
-
L.M. Masiello, J.S. Fotos, D.S. Galileo, and N.J. Karin Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells Bone 39 2006 72 82
-
(2006)
Bone
, vol.39
, pp. 72-82
-
-
Masiello, L.M.1
Fotos, J.S.2
Galileo, D.S.3
Karin, N.J.4
-
13
-
-
34147129569
-
Lysophosphatidic acid induces osteocyte dendrite outgrowth
-
S.A. Karagiosis, and N.J. Karin Lysophosphatidic acid induces osteocyte dendrite outgrowth Biochem. Biophys. Res. Commun. 357 2007 194 199
-
(2007)
Biochem. Biophys. Res. Commun.
, vol.357
, pp. 194-199
-
-
Karagiosis, S.A.1
Karin, N.J.2
-
14
-
-
0034783467
-
Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: Application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions
-
O. Peyruchaud, B. Winding, I. Pecheur, C.M. Serre, P. Delmas, and P. Clezardin Early detection of bone metastases in a murine model using fluorescent human breast cancer cells: application to the use of the bisphosphonate zoledronic acid in the treatment of osteolytic lesions J. Bone Miner. Res. 16 2001 2027 2034
-
(2001)
J. Bone Miner. Res.
, vol.16
, pp. 2027-2034
-
-
Peyruchaud, O.1
Winding, B.2
Pecheur, I.3
Serre, C.M.4
Delmas, P.5
Clezardin, P.6
-
15
-
-
15244343497
-
Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer
-
A. Boucharaba, C.-M. Serre, S. Gres, J.S. Saulnier-Blache, J.-C. Bordet, J. Guglielmi, P. Clezardin, and O. Peyruchaud Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer J. Clin. Invest. 114 2004 1714 1725
-
(2004)
J. Clin. Invest.
, vol.114
, pp. 1714-1725
-
-
Boucharaba, A.1
Serre, C.-M.2
Gres, S.3
Saulnier-Blache, J.S.4
Bordet, J.-C.5
Guglielmi, J.6
Clezardin, P.7
Peyruchaud, O.8
-
16
-
-
33745439822
-
The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases
-
A. Boucharaba, C.M. Serre, J. Guglielmi, J.C. Bordet, P. Clezardin, and O. Peyruchaud The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases Proc. Natl. Acad. Sci. U. S. A. 103 2006 9643 9648
-
(2006)
Proc. Natl. Acad. Sci. U. S. A.
, vol.103
, pp. 9643-9648
-
-
Boucharaba, A.1
Serre, C.M.2
Guglielmi, J.3
Bordet, J.C.4
Clezardin, P.5
Peyruchaud, O.6
-
17
-
-
0141570981
-
Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors
-
H. Ohta, K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, T. Watanabe, M. Yagi, M. Sato, R. Suzuki, H. Murooka, T. Sakai, T. Nishitoba, D.S. Im, H. Nochi, K. Tamoto, H. Tomura, and F. Okajima Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors Mol. Pharmacol. 64 2003 994 1005
-
(2003)
Mol. Pharmacol.
, vol.64
, pp. 994-1005
-
-
Ohta, H.1
Sato, K.2
Murata, N.3
Damirin, A.4
Malchinkhuu, E.5
Kon, J.6
Kimura, T.7
Tobo, M.8
Yamazaki, Y.9
Watanabe, T.10
Yagi, M.11
Sato, M.12
Suzuki, R.13
Murooka, H.14
Sakai, T.15
Nishitoba, T.16
Im, D.S.17
Nochi, H.18
Tamoto, K.19
Tomura, H.20
Okajima, F.21
more..
-
18
-
-
79951995418
-
Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist
-
J.S. Swaney, C. Chapman, L.D. Correa, K.J. Stebbins, A.R. Broadhead, G. Bain, A.M. Santini, J. Darlington, C.D. King, C.S. Baccei, C. Lee, T.A. Parr, J.R. Roppe, T.J. Seiders, J. Ziff, P. Prasit, J.H. Hutchinson, J.F. Evans, and D.S. Lorrain Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist J. Pharmacol. Exp. Ther. 336 2011 693 700
-
(2011)
J. Pharmacol. Exp. Ther.
, vol.336
, pp. 693-700
-
-
Swaney, J.S.1
Chapman, C.2
Correa, L.D.3
Stebbins, K.J.4
Broadhead, A.R.5
Bain, G.6
Santini, A.M.7
Darlington, J.8
King, C.D.9
Baccei, C.S.10
Lee, C.11
Parr, T.A.12
Roppe, J.R.13
Seiders, T.J.14
Ziff, J.15
Prasit, P.16
Hutchinson, J.H.17
Evans, J.F.18
Lorrain, D.S.19
-
19
-
-
77954321169
-
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
-
J.S. Swaney, C. Chapman, L.D. Correa, K.J. Stebbins, R.A. Bundey, P.C. Prodanovich, P. Fagan, C.S. Baccei, A.M. Santini, J.H. Hutchinson, T.J. Seiders, T.A. Parr, P. Prasit, J.F. Evans, and D.S. Lorrain A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model Br. J. Pharmacol. 160 2010 1699 1713
-
(2010)
Br. J. Pharmacol.
, vol.160
, pp. 1699-1713
-
-
Swaney, J.S.1
Chapman, C.2
Correa, L.D.3
Stebbins, K.J.4
Bundey, R.A.5
Prodanovich, P.C.6
Fagan, P.7
Baccei, C.S.8
Santini, A.M.9
Hutchinson, J.H.10
Seiders, T.J.11
Parr, T.A.12
Prasit, P.13
Evans, J.F.14
Lorrain, D.S.15
-
20
-
-
0027232391
-
The bioactive phospholipid lysophosphatidic acid is released from activated platelets
-
T. Eichholtz, K. Jalink, I. Fahrenfort, and W.H. Moolenaar The bioactive phospholipid lysophosphatidic acid is released from activated platelets Biochem. J. 291 1993 677 680
-
(1993)
Biochem. J.
, vol.291
, pp. 677-680
-
-
Eichholtz, T.1
Jalink, K.2
Fahrenfort, I.3
Moolenaar, W.H.4
-
21
-
-
0037073806
-
Serum lysophosphatidic acid is produced through diverse phospholipase pathways
-
J. Aoki, A. Taira, Y. Takanezawa, Y. Kishi, K. Hama, T. Kishimoto, K. Mizuno, K. Saku, R. Taguchi, and H. Arai Serum lysophosphatidic acid is produced through diverse phospholipase pathways J. Biol. Chem. 277 2002 48737 48744
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 48737-48744
-
-
Aoki, J.1
Taira, A.2
Takanezawa, Y.3
Kishi, Y.4
Hama, K.5
Kishimoto, T.6
Mizuno, K.7
Saku, K.8
Taguchi, R.9
Arai, H.10
-
22
-
-
33745466418
-
Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development
-
L.A. van Meeteren, P. Ruurs, C. Stortelers, P. Bouwman, M.A. van Rooijen, J.P. Pradere, T.R. Pettit, M.J. Wakelam, J.S. Saulnier-Blache, C.L. Mummery, W.H. Moolenaar, and J. Jonkers Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development Mol. Cell. Biol. 26 2006 5015 5022
-
(2006)
Mol. Cell. Biol.
, vol.26
, pp. 5015-5022
-
-
Van Meeteren, L.A.1
Ruurs, P.2
Stortelers, C.3
Bouwman, P.4
Van Rooijen, M.A.5
Pradere, J.P.6
Pettit, T.R.7
Wakelam, M.J.8
Saulnier-Blache, J.S.9
Mummery, C.L.10
Moolenaar, W.H.11
Jonkers, J.12
-
23
-
-
33847077525
-
Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors
-
P. Cui, J.L. Tomsig, W.F. McCalmont, S. Lee, C.J. Becker, K.R. Lynch, and T.L. Macdonald Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors Bioorg. Med. Chem. Lett. 17 2007 1634 1640
-
(2007)
Bioorg. Med. Chem. Lett.
, vol.17
, pp. 1634-1640
-
-
Cui, P.1
Tomsig, J.L.2
Mccalmont, W.F.3
Lee, S.4
Becker, C.J.5
Lynch, K.R.6
Macdonald, T.L.7
-
24
-
-
49949092545
-
Autotaxin (ATX): A multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties
-
L.M. Yuelling, and B. Fuss Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties Biochim. Biophys. Acta 1781 2008 525 530
-
(2008)
Biochim. Biophys. Acta
, vol.1781
, pp. 525-530
-
-
Yuelling, L.M.1
Fuss, B.2
-
25
-
-
12144286871
-
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
-
R.L. van Bezooijen, B.A. Roelen, A. Visser, L. van der Wee-Pals, E. de Wilt, M. Karperien, H. Hamersma, S.E. Papapoulos, P. ten Dijke, and C.W. Lowik Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist J. Exp. Med. 199 2004 805 814
-
(2004)
J. Exp. Med.
, vol.199
, pp. 805-814
-
-
Van Bezooijen, R.L.1
Roelen, B.A.2
Visser, A.3
Van Der Wee-Pals, L.4
De Wilt, E.5
Karperien, M.6
Hamersma, H.7
Papapoulos, S.E.8
Ten Dijke, P.9
Lowik, C.W.10
-
26
-
-
1542359873
-
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
-
M. Umezu-Goto, Y. Kishi, A. Taira, K. Hama, N. Dohmae, K. Takio, T. Yamori, G.B. Mills, K. Inoue, J. Aoki, and H. Arai Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production J. Cell Biol. 158 2002 227 233
-
(2002)
J. Cell Biol.
, vol.158
, pp. 227-233
-
-
Umezu-Goto, M.1
Kishi, Y.2
Taira, A.3
Hama, K.4
Dohmae, N.5
Takio, K.6
Yamori, T.7
Mills, G.B.8
Inoue, K.9
Aoki, J.10
Arai, H.11
-
27
-
-
2342437623
-
Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1
-
K. Hama, J. Aoki, M. Fukaya, Y. Kishi, T. Sakai, R. Suzuki, H. Ohta, T. Yamori, M. Watanabe, J. Chun, and H. Arai Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1 J. Biol. Chem. 279 2004 17634 17639
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 17634-17639
-
-
Hama, K.1
Aoki, J.2
Fukaya, M.3
Kishi, Y.4
Sakai, T.5
Suzuki, R.6
Ohta, H.7
Yamori, T.8
Watanabe, M.9
Chun, J.10
Arai, H.11
-
28
-
-
0031790774
-
Upregulation of endothelin-1 production by lysophosphatidic acid in rat aortic endothelial cells
-
C.C. Chua, R.C. Hamdy, and B.H. Chua Upregulation of endothelin-1 production by lysophosphatidic acid in rat aortic endothelial cells Biochim. Biophys. Acta 1405 1998 29 34
-
(1998)
Biochim. Biophys. Acta
, vol.1405
, pp. 29-34
-
-
Chua, C.C.1
Hamdy, R.C.2
Chua, B.H.3
-
29
-
-
0141479984
-
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
-
J.J. Yin, K.S. Mohammad, S.M. Kakonen, S. Harris, J.R. Wu-Wong, J.L. Wessale, R.J. Padley, I.R. Garrett, J.M. Chirgwin, and T.A. Guise A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases Proc. Natl. Acad. Sci. U. S. A. 100 2003 10954 10959
-
(2003)
Proc. Natl. Acad. Sci. U. S. A.
, vol.100
, pp. 10954-10959
-
-
Yin, J.J.1
Mohammad, K.S.2
Kakonen, S.M.3
Harris, S.4
Wu-Wong, J.R.5
Wessale, J.L.6
Padley, R.J.7
Garrett, I.R.8
Chirgwin, J.M.9
Guise, T.A.10
-
30
-
-
0037162093
-
Mitogenic action of LPA in prostate
-
Y. Daaka Mitogenic action of LPA in prostate Biochim. Biophys. Acta 1582 2002 265 269
-
(2002)
Biochim. Biophys. Acta
, vol.1582
, pp. 265-269
-
-
Daaka, Y.1
-
31
-
-
0037031878
-
Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells
-
Y. Xie, T.C. Gibbs, Y.V. Mukhin, and K.E. Meier Role for 18:1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells J. Biol. Chem. 277 2002 32516 32526
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 32516-32526
-
-
Xie, Y.1
Gibbs, T.C.2
Mukhin, Y.V.3
Meier, K.E.4
-
32
-
-
0034082879
-
Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
-
D.S. Im, C.E. Heise, M.A. Harding, S.R. George, B.F. O'Dowd, D. Theodorescu, and K.R. Lynch Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate Mol. Pharmacol. 57 2000 753 759
-
(2000)
Mol. Pharmacol.
, vol.57
, pp. 753-759
-
-
Im, D.S.1
Heise, C.E.2
Harding, M.A.3
George, S.R.4
O'dowd, B.F.5
Theodorescu, D.6
Lynch, K.R.7
-
33
-
-
60849120762
-
Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: Relevance to prostate cancer and benign hyperplasia
-
Y. Zeng, Y. Kakehi, M.A. Nouh, H. Tsunemori, M. Sugimoto, and X.X. Wu Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia Prostate 69 2009 283 292
-
(2009)
Prostate
, vol.69
, pp. 283-292
-
-
Zeng, Y.1
Kakehi, Y.2
Nouh, M.A.3
Tsunemori, H.4
Sugimoto, M.5
Wu, X.X.6
-
34
-
-
0037027752
-
Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein
-
Y. Li, and F.H. Sarkar Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein Cancer Lett. 186 2002 157 164
-
(2002)
Cancer Lett.
, vol.186
, pp. 157-164
-
-
Li, Y.1
Sarkar, F.H.2
-
35
-
-
43449127502
-
Prostate cancer
-
J.E. Damber, and G. Aus Prostate cancer Lancet 371 2008 1710 1721
-
(2008)
Lancet
, vol.371
, pp. 1710-1721
-
-
Damber, J.E.1
Aus, G.2
-
36
-
-
33748747873
-
Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells
-
R. Guo, E.A. Kasbohm, P. Arora, C.J. Sample, B. Baban, N. Sud, P. Sivashanmugam, N.H. Moniri, and Y. Daaka Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells Endocrinology 147 2006 4883 4892
-
(2006)
Endocrinology
, vol.147
, pp. 4883-4892
-
-
Guo, R.1
Kasbohm, E.A.2
Arora, P.3
Sample, C.J.4
Baban, B.5
Sud, N.6
Sivashanmugam, P.7
Moniri, N.H.8
Daaka, Y.9
-
37
-
-
2442701770
-
Interleukin 6 mediates the lysophosphatidic acid-regulated cross-talk between stromal and epithelial prostate cancer cells
-
P. Sivashanmugam, L. Tang, and Y. Daaka Interleukin 6 mediates the lysophosphatidic acid-regulated cross-talk between stromal and epithelial prostate cancer cells J. Biol. Chem. 279 2004 21154 21159
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 21154-21159
-
-
Sivashanmugam, P.1
Tang, L.2
Daaka, Y.3
-
38
-
-
0036893646
-
The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase
-
A. Grey, Q. Chen, K. Callon, X. Xu, I.R. Reid, and J. Cornish The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase Endocrinology 143 2002 4755 4763
-
(2002)
Endocrinology
, vol.143
, pp. 4755-4763
-
-
Grey, A.1
Chen, Q.2
Callon, K.3
Xu, X.4
Reid, I.R.5
Cornish, J.6
-
39
-
-
33745809904
-
Lysophosphatidic acid cooperates with 1alpha,25(OH)2D3 in stimulating human MG63 osteoblast maturation
-
J. Gidley, S. Openshaw, E.T. Pring, S. Sale, and J.P. Mansell Lysophosphatidic acid cooperates with 1alpha,25(OH)2D3 in stimulating human MG63 osteoblast maturation Prostaglandins Other Lipid Mediat. 80 2006 46 61
-
(2006)
Prostaglandins Other Lipid Mediat.
, vol.80
, pp. 46-61
-
-
Gidley, J.1
Openshaw, S.2
Pring, E.T.3
Sale, S.4
Mansell, J.P.5
-
40
-
-
79960843528
-
Lysophosphatidic acid and calcitriol co-operate to promote human osteoblastogenesis: requirement of albumin-bound LPA
-
J.P. Mansell, M. Nowghani, M. Pabbruwe, I.C. Paterson, A.J. Smith, and A.W. Blom Lysophosphatidic acid and calcitriol co-operate to promote human osteoblastogenesis: requirement of albumin-bound LPA Prostaglandins Other Lipid Mediat. 95 2011 45 52
-
(2011)
Prostaglandins Other Lipid Mediat.
, vol.95
, pp. 45-52
-
-
Mansell, J.P.1
Nowghani, M.2
Pabbruwe, M.3
Paterson, I.C.4
Smith, A.J.5
Blom, A.W.6
-
41
-
-
77749309902
-
LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4
-
Y.B. Liu, Y. Kharode, P.V. Bodine, P.J. Yaworsky, J.A. Robinson, and J. Billiard LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4 J. Cell. Biochem. 109 2010 794 800
-
(2010)
J. Cell. Biochem.
, vol.109
, pp. 794-800
-
-
Liu, Y.B.1
Kharode, Y.2
Bodine, P.V.3
Yaworsky, P.J.4
Robinson, J.A.5
Billiard, J.6
-
42
-
-
18344397194
-
LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing
-
X. Ye, K. Hama, J.J. Contos, B. Anliker, A. Inoue, M.K. Skinner, H. Suzuki, T. Amano, G. Kennedy, H. Arai, J. Aoki, and J. Chun LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing Nature 435 2005 104 108
-
(2005)
Nature
, vol.435
, pp. 104-108
-
-
Ye, X.1
Hama, K.2
Contos, J.J.3
Anliker, B.4
Inoue, A.5
Skinner, M.K.6
Suzuki, H.7
Amano, T.8
Kennedy, G.9
Arai, H.10
Aoki, J.11
Chun, J.12
-
43
-
-
79960587374
-
Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass
-
I. Gennero, S. Laurencin-Dalicieux, F. Conte-Auriol, F. Briand-Mesange, D. Laurencin, J. Rue, N. Beton, N. Malet, M. Mus, A. Tokumura, P. Bourin, L. Vico, G. Brunel, R.O. Oreffo, J. Chun, and J.P. Salles Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass Bone 49 2011 395 403
-
(2011)
Bone
, vol.49
, pp. 395-403
-
-
Gennero, I.1
Laurencin-Dalicieux, S.2
Conte-Auriol, F.3
Briand-Mesange, F.4
Laurencin, D.5
Rue, J.6
Beton, N.7
Malet, N.8
Mus, M.9
Tokumura, A.10
Bourin, P.11
Vico, L.12
Brunel, G.13
Oreffo, R.O.14
Chun, J.15
Salles, J.P.16
-
44
-
-
0036786445
-
Characterization of lpa(2)
-
Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2
-
J.J. Contos, I. Ishii, N. Fukushima, M.A. Kingsbury, X. Ye, S. Kawamura, J.H. Brown, and J. Chun Characterization of lpa(2) Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2 Mol. Cell. Biol. 22 2002 6921 6929
-
(2002)
Mol. Cell. Biol.
, vol.22
, pp. 6921-6929
-
-
Contos, J.J.1
Ishii, I.2
Fukushima, N.3
Kingsbury, M.A.4
Ye, X.5
Kawamura, S.6
Brown, J.H.7
Chun, J.8
-
45
-
-
78649737050
-
LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis
-
H. Sumida, K. Noguchi, Y. Kihara, M. Abe, K. Yanagida, F. Hamano, S. Sato, K. Tamaki, Y. Morishita, M.R. Kano, C. Iwata, K. Miyazono, K. Sakimura, T. Shimizu, and S. Ishii LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis Blood 116 2010 5060 5070
-
(2010)
Blood
, vol.116
, pp. 5060-5070
-
-
Sumida, H.1
Noguchi, K.2
Kihara, Y.3
Abe, M.4
Yanagida, K.5
Hamano, F.6
Sato, S.7
Tamaki, K.8
Morishita, Y.9
Kano, M.R.10
Iwata, C.11
Miyazono, K.12
Sakimura, K.13
Shimizu, T.14
Ishii, S.15
-
46
-
-
70149121909
-
Expression of autotaxin and acylglycerol kinase in prostate cancer: Association with cancer development and progression
-
M.A. Nouh, X.X. Wu, H. Okazoe, H. Tsunemori, R. Haba, A.M. Abou-Zeid, M.D. Saleem, M. Inui, M. Sugimoto, J. Aoki, and Y. Kakehi Expression of autotaxin and acylglycerol kinase in prostate cancer: association with cancer development and progression Cancer Sci. 2009
-
(2009)
Cancer Sci.
-
-
Nouh, M.A.1
Wu, X.X.2
Okazoe, H.3
Tsunemori, H.4
Haba, R.5
Abou-Zeid, A.M.6
Saleem, M.D.7
Inui, M.8
Sugimoto, M.9
Aoki, J.10
Kakehi, Y.11
-
47
-
-
0015784395
-
Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease
-
G.J. Gasic, T.B. Gasic, N. Galanti, T. Johnson, and S. Murphy Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease Int. J. Cancer 11 1973 704 718
-
(1973)
Int. J. Cancer
, vol.11
, pp. 704-718
-
-
Gasic, G.J.1
Gasic, T.B.2
Galanti, N.3
Johnson, T.4
Murphy, S.5
-
49
-
-
0024495699
-
Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin
-
J.M. Gerrard, and P. Robinson Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin Biochim. Biophys. Acta 1001 1989 282 285
-
(1989)
Biochim. Biophys. Acta
, vol.1001
, pp. 282-285
-
-
Gerrard, J.M.1
Robinson, P.2
-
50
-
-
15244351844
-
Platelets and metastasis revisited: A novel fatty link
-
G.P. Gupta, and J. Massague Platelets and metastasis revisited: a novel fatty link J. Clin. Invest. 114 2004 1691 1693
-
(2004)
J. Clin. Invest.
, vol.114
, pp. 1691-1693
-
-
Gupta, G.P.1
Massague, J.2
-
51
-
-
0029979014
-
Activation of human platelets by lysophosphatidic acid
-
M. Torti, E. Tolnai Festetics, A. Bertoni, F. Sinigaglia, and C. Balduini Activation of human platelets by lysophosphatidic acid Blood Coagul. Fibrinolysis 7 1996 253 255
-
(1996)
Blood Coagul. Fibrinolysis
, vol.7
, pp. 253-255
-
-
Torti, M.1
Tolnai Festetics, E.2
Bertoni, A.3
Sinigaglia, F.4
Balduini, C.5
-
52
-
-
0019822655
-
Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship
-
A. Tokumura, K. Fukuzawa, J. Isobe, and H. Tsukatani Lysophosphatidic acid-induced aggregation of human and feline platelets: structure-activity relationship Biochem. Biophys. Res. Commun. 99 1981 391 398
-
(1981)
Biochem. Biophys. Res. Commun.
, vol.99
, pp. 391-398
-
-
Tokumura, A.1
Fukuzawa, K.2
Isobe, J.3
Tsukatani, H.4
-
53
-
-
40749134619
-
Individual heterogeneity in platelet response to lysophosphatidic acid: Evidence for a novel inhibitory pathway
-
Z. Pamuklar, J.S. Lee, H.Y. Cheng, M. Panchatcharam, S. Steinhubl, A.J. Morris, R. Charnigo, and S.S. Smyth Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway Arterioscler. Thromb. Vasc. Biol. 28 2008 555 561
-
(2008)
Arterioscler. Thromb. Vasc. Biol.
, vol.28
, pp. 555-561
-
-
Pamuklar, Z.1
Lee, J.S.2
Cheng, H.Y.3
Panchatcharam, M.4
Steinhubl, S.5
Morris, A.J.6
Charnigo, R.7
Smyth, S.S.8
-
54
-
-
65449156892
-
Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis
-
Z. Pamuklar, L. Federico, S. Liu, M. Umezu-Goto, A. Dong, M. Panchatcharam, Z. Fulerson, E. Berdyshev, V. Natarajan, X. Fang, L.A. van Meeteren, W.H. Moolenaar, G.B. Mills, A.J. Morris, and S.S. Smyth Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis J. Biol. Chem. 284 2009 7385 7394
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 7385-7394
-
-
Pamuklar, Z.1
Federico, L.2
Liu, S.3
Umezu-Goto, M.4
Dong, A.5
Panchatcharam, M.6
Fulerson, Z.7
Berdyshev, E.8
Natarajan, V.9
Fang, X.10
Van Meeteren, L.A.11
Moolenaar, W.H.12
Mills, G.B.13
Morris, A.J.14
Smyth, S.S.15
-
55
-
-
80053131625
-
Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells
-
Z. Fulkerson, T. Wu, M. Sunkara, C.V. Kooi, A.J. Morris, and S.S. Smyth Binding of autotaxin to integrins localizes lysophosphatidic acid production to platelets and mammalian cells J. Biol. Chem. 286 2011 34654 34663
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 34654-34663
-
-
Fulkerson, Z.1
Wu, T.2
Sunkara, M.3
Kooi, C.V.4
Morris, A.J.5
Smyth, S.S.6
-
56
-
-
44649092795
-
P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: A signaling axis promoting osteogenesis
-
N. Panupinthu, J.T. Rogers, L. Zhao, L.P. Solano-Flores, F. Possmayer, S.M. Sims, and S.J. Dixon P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis J. Cell Biol. 181 2008 859 871
-
(2008)
J. Cell Biol.
, vol.181
, pp. 859-871
-
-
Panupinthu, N.1
Rogers, J.T.2
Zhao, L.3
Solano-Flores, L.P.4
Possmayer, F.5
Sims, S.M.6
Dixon, S.J.7
-
57
-
-
78650305975
-
Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain
-
T. Yoneda, K. Hata, M. Nakanishi, M. Nagae, T. Nagayama, H. Wakabayashi, T. Nishisho, T. Sakurai, and T. Hiraga Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain Bone 48 2011 100 105
-
(2011)
Bone
, vol.48
, pp. 100-105
-
-
Yoneda, T.1
Hata, K.2
Nakanishi, M.3
Nagae, M.4
Nagayama, T.5
Wakabayashi, H.6
Nishisho, T.7
Sakurai, T.8
Hiraga, T.9
-
58
-
-
77949492248
-
Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance
-
M.E. Lin, D.R. Herr, and J. Chun Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance Prostaglandins Other Lipid Mediat. 91 2010 130 138
-
(2010)
Prostaglandins Other Lipid Mediat.
, vol.91
, pp. 130-138
-
-
Lin, M.E.1
Herr, D.R.2
Chun, J.3
-
59
-
-
77954310586
-
The sensitization of peripheral C-fibers to lysophosphatidic acid in bone cancer pain
-
J. Zhao, H.L. Pan, T.T. Li, Y.Q. Zhang, J.Y. Wei, and Z.Q. Zhao The sensitization of peripheral C-fibers to lysophosphatidic acid in bone cancer pain Life Sci. 2010
-
(2010)
Life Sci.
-
-
Zhao, J.1
Pan, H.L.2
Li, T.T.3
Zhang, Y.Q.4
Wei, J.Y.5
Zhao, Z.Q.6
-
60
-
-
78649500338
-
Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCepsilon pathway in dorsal root ganglion neurons
-
H.L. Pan, Y.Q. Zhang, and Z.Q. Zhao Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCepsilon pathway in dorsal root ganglion neurons Mol. Pain 6 2010 85
-
(2010)
Mol. Pain
, vol.6
, pp. 85
-
-
Pan, H.L.1
Zhang, Y.Q.2
Zhao, Z.Q.3
-
62
-
-
68549104359
-
Circulating and disseminated tumor cells in the management of breast cancer
-
J.S. Ross, and E.A. Slodkowska Circulating and disseminated tumor cells in the management of breast cancer Am. J. Clin. Pathol. 132 2009 237 245
-
(2009)
Am. J. Clin. Pathol.
, vol.132
, pp. 237-245
-
-
Ross, J.S.1
Slodkowska, E.A.2
-
63
-
-
63049121364
-
The metastatic niche: Adapting the foreign soil
-
B. Psaila, and D. Lyden The metastatic niche: adapting the foreign soil Nat. Rev. Cancer 9 2009 285 293
-
(2009)
Nat. Rev. Cancer
, vol.9
, pp. 285-293
-
-
Psaila, B.1
Lyden, D.2
-
64
-
-
0032973197
-
Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta
-
K. Horiuchi, N. Amizuka, S. Takeshita, H. Takamatsu, M. Katsuura, H. Ozawa, Y. Toyama, L.F. Bonewald, and A. Kudo Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta J. Bone Miner. Res. 14 1999 1239 1249
-
(1999)
J. Bone Miner. Res.
, vol.14
, pp. 1239-1249
-
-
Horiuchi, K.1
Amizuka, N.2
Takeshita, S.3
Takamatsu, H.4
Katsuura, M.5
Ozawa, H.6
Toyama, Y.7
Bonewald, L.F.8
Kudo, A.9
-
65
-
-
67650451085
-
The multifaceted role of periostin in tumorigenesis
-
K. Ruan, S. Bao, and G. Ouyang The multifaceted role of periostin in tumorigenesis Cell Mol. Life Sci. 66 2009 2219 2230
-
(2009)
Cell Mol. Life Sci.
, vol.66
, pp. 2219-2230
-
-
Ruan, K.1
Bao, S.2
Ouyang, G.3
-
66
-
-
84855425160
-
Interactions between cancer stem cells and their niche govern metastatic colonization
-
I. Malanchi, A. Santamaria-Martinez, E. Susanto, H. Peng, H.A. Lehr, J.F. Delaloye, and J. Huelsken Interactions between cancer stem cells and their niche govern metastatic colonization Nature 481 2012 85 89
-
(2012)
Nature
, vol.481
, pp. 85-89
-
-
Malanchi, I.1
Santamaria-Martinez, A.2
Susanto, E.3
Peng, H.4
Lehr, H.A.5
Delaloye, J.F.6
Huelsken, J.7
-
67
-
-
84868549543
-
Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases
-
S. Contie, N. Voorzanger-Rousselot, J. Litvin, P. Clezardin, and P. Garnero Increased expression and serum levels of the stromal cell-secreted protein periostin in breast cancer bone metastases Int. J. Cancer 2010
-
(2010)
Int. J. Cancer
-
-
Contie, S.1
Voorzanger-Rousselot, N.2
Litvin, J.3
Clezardin, P.4
Garnero, P.5
-
68
-
-
84868587016
-
Lysophosphatidic acid-induced expression of periostin in stromal cells: Prognoistic relevance of periostin expression in epithelial ovarian cancer
-
K.U. Choi, J.S. Yun, I.H. Lee, S.C. Heo, S.H. Shin, E.S. Jeon, Y.J. Choi, D.S. Suh, M.S. Yoon, and J.H. Kim Lysophosphatidic acid-induced expression of periostin in stromal cells: Prognoistic relevance of periostin expression in epithelial ovarian cancer Int. J. Cancer 2010
-
(2010)
Int. J. Cancer
-
-
Choi, K.U.1
Yun, J.S.2
Lee, I.H.3
Heo, S.C.4
Shin, S.H.5
Jeon, E.S.6
Choi, Y.J.7
Suh, D.S.8
Yoon, M.S.9
Kim, J.H.10
-
69
-
-
83455208311
-
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors
-
X. Lu, E. Mu, Y. Wei, S. Riethdorf, Q. Yang, M. Yuan, J. Yan, Y. Hua, B.J. Tiede, B.G. Haffty, K. Pantel, J. Massague, and Y. Kang VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors Cancer Cell 20 2011 701 714
-
(2011)
Cancer Cell
, vol.20
, pp. 701-714
-
-
Lu, X.1
Mu, E.2
Wei, Y.3
Riethdorf, S.4
Yang, Q.5
Yuan, M.6
Yan, J.7
Hua, Y.8
Tiede, B.J.9
Haffty, B.G.10
Pantel, K.11
Massague, J.12
Kang, Y.13
-
70
-
-
77951211094
-
Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65
-
H. Shimada, and L.E. Rajagopalan Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65 J. Biol. Chem. 285 2010 12536 12542
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 12536-12542
-
-
Shimada, H.1
Rajagopalan, L.E.2
-
71
-
-
0032835220
-
Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction
-
C. Rizza, N. Leitinger, J. Yue, D.J. Fischer, D.A. Wang, P.T. Shih, H. Lee, G. Tigyi, and J.A. Berliner Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction Lab. Invest. 79 1999 1227 1235
-
(1999)
Lab. Invest.
, vol.79
, pp. 1227-1235
-
-
Rizza, C.1
Leitinger, N.2
Yue, J.3
Fischer, D.J.4
Wang, D.A.5
Shih, P.T.6
Lee, H.7
Tigyi, G.8
Berliner, J.A.9
-
72
-
-
0037162084
-
Structure-activity relationships of lysophosphatidic acid analogs
-
K.R. Lynch, and T.L. Macdonald Structure-activity relationships of lysophosphatidic acid analogs Biochim. Biophys. Acta 1582 2002 289 294
-
(2002)
Biochim. Biophys. Acta
, vol.1582
, pp. 289-294
-
-
Lynch, K.R.1
Macdonald, T.L.2
-
73
-
-
0042887042
-
The emerging role of lysophosphatidic acid in cancer
-
G.B. Mills, and W.H. Moolenaar The emerging role of lysophosphatidic acid in cancer Nat. Rev. Cancer 3 2003 582 591
-
(2003)
Nat. Rev. Cancer
, vol.3
, pp. 582-591
-
-
Mills, G.B.1
Moolenaar, W.H.2
-
74
-
-
65649132676
-
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases
-
S. Liu, M. Umezu-Goto, M. Murph, Y. Lu, W. Liu, F. Zhang, S. Yu, L.C. Stephens, X. Cui, G. Murrow, K. Coombes, W. Muller, M.C. Hung, C.M. Perou, A.V. Lee, X. Fang, and G.B. Mills Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases Cancer Cell 15 2009 539 550
-
(2009)
Cancer Cell
, vol.15
, pp. 539-550
-
-
Liu, S.1
Umezu-Goto, M.2
Murph, M.3
Lu, Y.4
Liu, W.5
Zhang, F.6
Yu, S.7
Stephens, L.C.8
Cui, X.9
Murrow, G.10
Coombes, K.11
Muller, W.12
Hung, M.C.13
Perou, C.M.14
Lee, A.V.15
Fang, X.16
Mills, G.B.17
-
75
-
-
56749151299
-
Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells
-
S. Yu, M.M. Murph, Y. Lu, S. Liu, H.S. Hall, J. Liu, C. Stephens, X. Fang, and G.B. Mills Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells J. Natl. Cancer Inst. 100 2008 1630 1642
-
(2008)
J. Natl. Cancer Inst.
, vol.100
, pp. 1630-1642
-
-
Yu, S.1
Murph, M.M.2
Lu, Y.3
Liu, S.4
Hall, H.S.5
Liu, J.6
Stephens, C.7
Fang, X.8
Mills, G.B.9
-
76
-
-
59449091267
-
Role of LPA4/p2y9/GPR23 in negative regulation of cell motility
-
Z. Lee, C.T. Cheng, H. Zhang, M.A. Subler, J. Wu, A. Mukherjee, J.J. Windle, C.K. Chen, and X. Fang Role of LPA4/p2y9/GPR23 in negative regulation of cell motility Mol. Biol Cell 2008
-
(2008)
Mol. Biol Cell
-
-
Lee, Z.1
Cheng, C.T.2
Zhang, H.3
Subler, M.A.4
Wu, J.5
Mukherjee, A.6
Windle, J.J.7
Chen, C.K.8
Fang, X.9
-
77
-
-
83355173005
-
LPA is a chemorepellent for B16 melanoma cells: Action through the cAMP-Elevating LPA5 receptor
-
M. Jongsma, E. Matas-Rico, A. Rzadkowski, K. Jalink, and W.H. Moolenaar LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor PLoS One 6 2011 e29260
-
(2011)
PLoS One
, vol.6
, pp. 29260
-
-
Jongsma, M.1
Matas-Rico, E.2
Rzadkowski, A.3
Jalink, K.4
Moolenaar, W.H.5
-
78
-
-
0034726004
-
Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors
-
K. Bandoh, J. Aoki, A. Taira, M. Tsujimoto, H. Arai, and K. Inoue Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors FEBS Lett. 478 2000 159 165
-
(2000)
FEBS Lett.
, vol.478
, pp. 159-165
-
-
Bandoh, K.1
Aoki, J.2
Taira, A.3
Tsujimoto, M.4
Arai, H.5
Inoue, K.6
-
79
-
-
27144538692
-
Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells
-
Y. Fujiwara, V. Sardar, A. Tokumura, D. Baker, K. Murakami-Murofushi, A. Parrill, and G. Tigyi Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells J. Biol. Chem. 280 2005 35038 35050
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 35038-35050
-
-
Fujiwara, Y.1
Sardar, V.2
Tokumura, A.3
Baker, D.4
Murakami-Murofushi, K.5
Parrill, A.6
Tigyi, G.7
-
80
-
-
77953778656
-
A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation
-
J. Gierse, A. Thorarensen, K. Beltey, E. Bradshaw-Pierce, L. Cortes-Burgos, T. Hall, A. Johnston, M. Murphy, O. Nemirovskiy, S. Ogawa, L. Pegg, M. Pelc, M. Prinsen, M. Schnute, J. Wendling, S. Wene, R. Weinberg, A. Wittwer, B. Zweifel, and J. Masferrer A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation J. Pharmacol. Exp. Ther. 334 2010 310 317
-
(2010)
J. Pharmacol. Exp. Ther.
, vol.334
, pp. 310-317
-
-
Gierse, J.1
Thorarensen, A.2
Beltey, K.3
Bradshaw-Pierce, E.4
Cortes-Burgos, L.5
Hall, T.6
Johnston, A.7
Murphy, M.8
Nemirovskiy, O.9
Ogawa, S.10
Pegg, L.11
Pelc, M.12
Prinsen, M.13
Schnute, M.14
Wendling, J.15
Wene, S.16
Weinberg, R.17
Wittwer, A.18
Zweifel, B.19
Masferrer, J.20
more..
|